{"cluster": 22, "subcluster": 1, "abstract_summ": "Overall, results obtained suggest that the spread of the pandemic SARS-CoV-2 virus did not substantially affect the time trend of other respiratory infections in our region, highlighting no significant difference in rates of SARS-CoV-2 infection in patients with or without other respiratory pathogens.CONCLUSIONS: Respiratory viral pathogens accounted for a considerable number of positive results but no SARS-CoV-2 case was identified before the end of March 2020.OBJECTIVES: To describe the first isolation and sequencing of SARS\u2010CoV\u20102 in Australia and rapid sharing of the isolate.Therefore, in the present scenario of COVID-19 pandemic, differential diagnosis resulting positive for common respiratory pathogen(s) should not exclude testing of SARS-CoV-2.In the current research, we report results of our studying SARS-CoV-2 spread in Russia and adaptation of Russian population to it in March-June 2020.In the latter, SARS-CoV-2 positive persons comprised 5.37% in March and 11.42% in June 2020.Rhinoviruses accounted for the largest co-infection part (7.91% of samples tested positive for SARS-CoV-2); respiratory syncytial virus 7.03%; adenoviruses 4.84%; metapneumoviruses 3.29%; parainfluenza viruses 2.42%; enterovirus D68 1.10% and some other viruses (entero-, echo-, parecho-) less than 1%.", "title_summ": "The specificity of Japanese PCR assays for SARS-CoV-2 exceeds 99.7%Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory virusesEpidemiology of SARS-CoV-2 Emergence Amidst Community-Acquired Respiratory VirusesNo SARS-CoV-2 detection in the German CAPNETZ cohort of community acquired pneumonia before COVID-19 peak in March 2020Isolation and rapid sharing of the 2019 novel coronavirus (SARS\u2010CoV\u20102) from the first patient diagnosed with COVID\u201019 in AustraliaSARS-CoV-2 screening test for Japanese returnees from Wuhan, China, January 2020Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic LaboratoriesTrend of respiratory pathogens during the covid-19 epidemicAdaptation of Russian population to SARS-CoV-2: Asymptomatic course, comorbidities, mortality, and other respiratory viruses \u2013 A reply to Fear versus Data: Short Communication to International Journal of Antimicrobial AgentsMolecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experienceRetrospective detection of SARS-CoV-2 in hospitalized patients with influenza-like illness.", "title_abstract_phrases": "Overall, results obtained suggest that the spread of the pandemic SARS-CoV-2 virus did not substantially affect the time trend of other respiratory infections in our region, highlighting no significant difference in rates of SARS-CoV-2 infection in patients with or without other respiratory pathogens.Therefore, in the present scenario of COVID-19 pandemic, differential diagnosis resulting positive for common respiratory pathogen(s) should not exclude testing of SARS-CoV-2.Adaptation of Russian population to SARS-CoV-2: Asymptomatic course, comorbidities, mortality, and other respiratory viruses \u2013 A reply to Fear versus Data: Short Communication to International Journal of Antimicrobial AgentsIn the current research, we report results of our studying SARS-CoV-2 spread in Russia and adaptation of Russian population to it in March-June 2020.Our statistical analysis is consistent with Jonathan MR et al, if the specificity of SARS-CoV-2 PCR assays in Japan exceeds 99.7%.Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory virusesIntroduction: Rapid diagnosis and isolation are key to containing the rapid spread of a pandemic agent like SARS-CoV-2, which has spread globally since its initial outbreak in Wuhan province in China.CONCLUSIONS: Respiratory viral pathogens accounted for a considerable number of positive results but no SARS-CoV-2 case was identified before the end of March 2020.Isolation and rapid sharing of the 2019 novel coronavirus (SARS\u2010CoV\u20102) from the first patient diagnosed with COVID\u201019 in AustraliaOBJECTIVES: To describe the first isolation and sequencing of SARS\u2010CoV\u20102 in Australia and rapid sharing of the isolate.In the latter, SARS-CoV-2 positive persons comprised 5.37% in March and 11.42% in June 2020."}